Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neonatal HIV Early Infant Diagnosis (EID) Versus Standard of Care EID - Long Term Impact on inFant hEalth: a Feasibility Study of point-of Care Testing at Birth Versus at 6 Weeks of Age, on the Uptake of ART and Infant Prophylaxis, and on Rates of Infant Survival, Morbidity and Retention in Care

NCT04032522 is registered in ClinicalTrials.gov with Michael Hoelscher as lead sponsor.

NCT NCT04032522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04032522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neonatal HIV Early Infant Diagnosis (EID) Versus Standard of Care EID - Long Term Impact on inFant hEalth: a Feasibility Study of point-of Care Testing at Birth Versus at 6 Weeks of Age, on the Uptake of ART and Infant Prophylaxis, and on Rates of Infant Survival, Morbidity and Retention in Care
Lead sponsor
Michael Hoelscher
Phase
Observational
Overall status
Completed
Start date
October 23, 2019
Completion date
January 1, 2023
Enrollment
6,602 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, neonatal hiv early-infant-diagnosis (eid), point-of-care testing (poc)